Breaking News

Asymchem Opens New R&D Site Near Boston

The new site is focused on providing early-stage R&D services including chemical process development, pre-formulation study and formulation development.

Author Image

By: Charlie Sternberg

Associate Editor

Asymchem Laboratories (Tianjin) Co. Ltd., a CDMO serving the global pharmaceutical and biotech industry, has opened a new site in Woburn, Massachusetts.   Asymchem Boston, a wholly owned subsidiary of Asymchem Group, marks an important step toward expanding Asymchem’s global footprint. The new Boston site is focused on providing early-stage R&D services including chemical process development, pre-formulation study and formulation development for small molecules, peptides and oligonuc...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters